Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Massachusetts Senior Drug Coverage Revives Catastrophic Plan, Adds PBMs

Executive Summary

The Massachusetts legislature is about to consider a senior drug plan which resurrects much of the design of the graduated contribution/catastrophic drug coverage enacted for Medicare in 1988, and combines it with the new feature of administration by an aggressive private sector PBM.

You may also be interested in...



Massachusetts Senior Rx Plan Nears Selection Of PBM To Administer Program

Massachusetts expects to select a pharmacy benefit management company by the end of January for the state's prescription drug insurance program for the elderly. The Rx plan is scheduled to be operational in the second quarter of 2001.

Massachusetts Senior Rx Plan Nears Selection Of PBM To Administer Program

Massachusetts expects to select a pharmacy benefit management company by the end of January for the state's prescription drug insurance program for the elderly. The Rx plan is scheduled to be operational in the second quarter of 2001.

PhRMA and Mass Biotech Council To Testify Against Drug Pricing/Rebate Bill

PhRMA and the Massachusetts Biotechnology Council will testify June 29 against a Massachusetts state bill (HB 2886) that would reduce the cost of outpatient pharmaceuticals through mandated rebates and discounts.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS035861

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel